Increased susceptibility to Helicobacter pylori infection in pregnancy. by Lanciers, S et al.
Infectious Diseases in Obstetrics and Gynecology 7:195-198 (1999)
(C) 1999 Wiley-Liss, Inc.
Increased Susceptibility to Helicobacter pylori Infection
in Pregnancy
S. Lanciers,,2 B. Despinasse, 1 D.I. Mehta,3 and U. Blecker2,3
1Division of Pediatric Gastroenterology, Louisiana State University Medical Center,
New Orleans, LA
eDivision of Pediatric Gastroenterology, Academic Children’s Hospital, Free University of
Brussels, Belgium
3Division of Pediatric Gastroenterology, Alfred L duPont Hospitalfor Children, Wilmington, DE
ABSTRACT
Objective: Helicobacter pylori plays, a major role in abdominal symptoms and gastroduodenal pa-
thology, including gastric cancer. Pregnancy has been associated with changes in both humoral and
cell-mediated immunity. These changes include alterations in the various classes of antibodies
during different gestational periods. It has been previously suggested that these alterations may
expose pregnant women to an increased risk of infection with this microorganism.
Methods: To further investigate this hypothesis, we assayed sera from 229 asymptomatic preg-
nant women for the presence of H.-pylori-specific immunoglobulin G (IgG) and immunoglobulinM
(IgM) antibodies by means of a commercially available serum ELISA test (MalakitTM, Biolab,
Belgium). Both tests were previously validated in large series of H.-pylori-positive and -negative
subjects. While the presence of H..pylori-specific IgG antibodies is only a marker for a "chronic"
infection with this bacterium and therefore no indicator of the time of acquisition of the infection,
specific IgM antibodies are a more specific marker for a recently acquired infection with H. pylori.
Results were compared with those previously obtained in asymptomatic, healthy, nonpregnant
individuals.
Results: One hundred twenty of 229 women (52.4%) and 55/118 nonpregnant subjects (46.6%)
were seropositive for H.-pylori-specific IgG antibodies (P > 0.3). Out of these 120 IgG-antibody-
positive women, 36 (30%) were positive for H.-pylori-specific IgM antibodies, as were 25/109
(22.9%) in the IgG-antibody-negative group (P > 0.3). Overall, 61/229 (26.6%) of the pregnant
women had recently been infected with H. pylori, compared with 11% of the healthy, nonpregnant
population (P > 0.01).
Conclusions: Our observations confirm the possibility of an increased susceptibility to H. pylori
infection in pregnancy. Additional studies are necessary to further understand the immune re-
sponse to H. pylori in pregnancy. Infect. Dis. Obstet. Gynecol. 7:195-198, 1999.
(C) 1999 Wiley-Liss, Inc.
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Ie/icobacterpylori has been found to be the ma-
jor cause for gastroduodenal pathology, both
in adults 1,z and in children,3, 4 a finding that re-
suited in a new understanding of and approach to
chronic active gastritis, duodenal ulcers, and, to a
lesser degree, gastric ulcers.
The exact route of transmission of H. pylori is
still not well understood. We know that the human
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body is the only natural reservoir for H. pylori and
that, therefore, person-to-person transmission is
the most likely method of transmission,s A number
of factors, such as crowding index,
6 low socioeco-
nomic status,7 an infected family member.,8 and
ethnicity,
9 have all been linked to a higher inci-
dence of H. pylori infection.
Recently it has been suggested that this bacte-
rium might play an important role as a cofactor in
the development of gastric adenocarcinoma1,11
and lymphoma, lz,3 H. pylori infectiofi increases
with advancing age.4 We previously demonstrated
that H. pylori infection is also present in symptom-
free subjects, both in childrens and adults. 16
Pregnancy has been associated with changes in
both humoral and cell-mediated immunity. Al-
though not yet completely understood, these
changes include alterations in the various classes of
antibodies during different gestational periods,
which may lead to an increased susceptibility to
certain infections.7 Our study was designed to ex-
plore whether pregnant women are at an increased
risk for acquiring H. pylori infection due to immu-
nological changes that occur during pregnancy.
To minimize potential differences in risk factors
between the investigated groups, all subjects were
pooled from the same population and matched for
age and socioeconomic background.
METHODS
Patients
We investigated 229 healthy pregnant women
(ages 20 to 40 years) and 118 healthy nonpregnant
women (ages 18 to 40 years) for the presence of
H.-pylori-specific antibodies. The subjects were
Caucasians of middle to upper socioeconomic class
and background and were matched for age. Both
groups were asymptomatic with regard to gastroin-
testinal symptoms and were not taking any antibi-
otics, He-blockers, or proton pump inhibitors for at
least 6 weeks. Pregnant women were tested at rou-
tine prenatal visits during their second trimester.
The control group was comprised of women who
were tested during routine prenatal screening. As
mentioned above, the exact route of transmission
and risk factors for H. pylori infection are still not
quite understood. To minimize the impact of any
such risk factors, all investigated subjects were
drawn from the same population.
Serology
The sera were tested using the MalakitTM Helico-
bacterpylori series (Biolab S.A., Limal, Belgium), a
solid-phase (microwells) two-step indirect ELISA
method based on the sandwich principle for the
detection of specific immunoglobulin M (IgM) or
immunoglobulin G (IgG) antibodies to H. pylori in
human sera. This assay uses fractionated and puri-
fied antigens for H. pylori. During the first step,
samples and controls are diluted 1:200 and incu-
bated in microwells at 37C for 45 minutes to form
an H. pylori antigen/anti-H.-py/ori-antibody com-
plex. The unbound components are washed off. In
the subsequent incubation (at 37C for 45 min-
utes), a rabbit anti-human-IgM peroxidase conju-
gate is added to react with the H. py/ori antigen/
anti-H.-pylori-antibody complexes. Unreacted con-
jugate is washed off. After the addition of
azinobenzthiazoline sulfonate (ABTS) and a last
incubation step (at 37C for 60 minutes), the en-
zymatic reaction is stopped with a fixator (NaOH).
The intensity of the green coloration is mea-
sured at 405 nm and is directly proportional to the
amount of anti-H, pylori antibodies in the sample. A
positive control giving an absorbency higher than
1,000 is used to ensure that the entire test protocol
is working properly.
A positive result for H.-pylori-specific IgM anti-
bodies by this ELISA technique was defined as an
IgG level two or more standard deviations above
the mean of all negative IgG and IgM titers previ-
ously obtained by the company (company’s unpub-
lished data) and our group. 18,9
Statistics
The Fisher exact test was used for statistical cal-
culations.
RESULTS
One hundred twenty of 229 pregnant (52.4%) and
55/118 (46.6%) nonpregnant women were positive
for H.-pylori-specific IgG antibodies (P > 0.3). Out
of the 120 IgG-antibody-positive pregnant women,
36 (30%) were positive for H.-pylori-specific IgM
antibodies, as were 25/109 (22.9%) in the IgG-
antibody-negative group (P > 0.3).
In the nonpregnant control group, 8/55 (14.5%)
IgG-positive and 5/63 (7.9%) IgG-negative subjects
were positive for H.-pylori-specific IgM antibodies.
Overall, 61/229 (26.6%) of the pregnant women
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had recently been infected with H. pylori, as de-
fined by positivity for specific IgM antibodies,
compared with 13/118 (11%) in the nonpregnant
population (P > 0.01). This reflects a relative risk of
2.21 (95% confidence interval, 2.02-2.40) of be-
coming infected with H. pylori during pregnancy (P
> 0.01).
DISCUSSION
Pregnancy is associated with a number of modifi-
cations and adaptations. Although it has been well
established that immunoregulation and immuno-
modulation occur during pregnancy, it is important
to fully understand the effects these changes have
on a pregnant woman’s susceptibility to infectious
agents. In this study we sought to elucidate wheth-
er pregnant women are at an increased risk for ac-
quiring H. pylori infection.
Prior studies have confirmed the prevalence of
H. pylori seropositivity in asymptomatic children
and adults.1s,6 H. pylori has been linked to chronic
gastritis, peptic ulcer disease and, to a lesser extent,
gastric adenocarcinoma and gastric lymphoprolif-
erative disease, specifically low-grade B-cell lym-
phoma. 1,,le,z In view of the important pathogen-
esis of H. pylori, it is important to investigate the
maternal history of H. pylori infection in/-t.-pylori-
positive pregnant women.
Recently, we investigated the role of passive im-
munity and the evolution of H. pylori infection in
children born to mothers with active H. pylori in-
fection from parturition to twelve months of age.
We were able to demonstrate that these infants do
not appear to have an increased risk of developing
H. pylori infection during their first year of life. el
Looking at asymptomatic women in both the
pregnant and control groups, the pregnant women
in our study had a significantly higher relative risk
of acquiring the disease. Therefore, this study con-
firms the possibility of an increased risk of acquir-
ing H. pylori infection during pregnancy.
The presence of H.-pylori-specific IgG has not
been shown to be protective. In addition, both
groups had comparable prevalences for anti-H.-
pylori IgG antibodies. This excludes the possibility
of IgG titers as a cause for the increased incidence
of specific IgM antibodies in our pregnant popula-
tion.
During pregnancy, physiologic alterations occur
that increase the potential for gastrointestinal
symptoms; in late pregnancy the rise in serum pro-
gesterone levels causes lower esophageal sphincter
tone to decrease.7 Additionally, intragastric pres-
sure increases and the intraesophageal pressure de-
creases while gastric pH and gastric acid output
remain unchanged.7 But pregnancy may also con-
vey a relative protective effect against the forma-
tion of peptic ulcer disease. With the above noted,
there remains the possibility that the well-known
increased incidence of gastrointestinal symptom-
atology during pregnancyz2 is related to H. pylori
disease. Recently it has been suggested that H.
pylori infection may cause hyperemises gravida-
rum.z3
Follow-up studies are needed to delineate the
pregnant women’s complete immune response in
the face of infection with H. pylori. As we better
understand the pregnant host’s immune response,
it will aid in the prevention of future disease
through possible prenatal screening exams and vac-
cination programs, as well as possible pharmaco-
therapy and immunotherapy alternatives.
Based on our findings of an increased incidence
of H. pylori infection during pregnancy, further
studies may be required to investigate the indica-
tion of screening for H. pylori in pregnant women.
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